An AAV-ie based Vaccine effectively protects against SARS-CoV-2 and Circulating Variants
S. Zhao, F. Tan, J. Ke, J. Yang, C.-b. Lin, H. Wang, g. zhong
This study develops an AAV-ie-S1 vaccine that neutralizes SARS-CoV-2 variants B.1.1.7 and B.1.351, offering protection against emerging strains.
bioRxiv · May 19, 2021 · PreprintMicrobiology